J Mitra Launches India’s First Dengue NS1 Antigen Self-Test

New Delhi: J Mitra & Company has revitalised its war against dengue by launching the Dengue NS1 Antigen self-test kit. This is the first self-test/home-test kit launched by any company in India.

It detects dengue on the first day of fever; it is self-administrable – anyone can conduct the test on their own and in any location; Results are available within 20 mins.

Using the Dengue NS1 Antigen self-test is a straightforward, 2-step process – add one drop of blood into the sample well; add one drop of assay buffer; allow the reaction to occur for 20 minutes and read the result.

The Dengue NS1 Antigen self-test is a proactive tool that can detect the Dengue NS1 Antigen from Day One as soon as the symptoms appear in patients. This early detection capability empowers individuals to take control of their health and seek timely medical intervention. NS1 Antigen can be detected in both primary and secondary dengue infections. However, NS1 is challenging to detect once anti-NS1 Antibodies appear. NS1 Antigen is present at high concentrations in the sera of Dengue virus-infected patients during the early clinical phase of the disease.

Dengue is amongst the top 10 most communicable diseases in India, and the most affected states include Uttar Pradesh, West Bengal, Bihar, Karnataka, Maharashtra, Kerala, Delhi, Rajasthan, Punjab and Odisha.

Related Posts

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Andelyn bio sciences Inc, a leading patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Queen’s University to develop and manufacture AAV9-GM2, a gene therapy…

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

Cellution Biologics Inc, a biologics company focused on developing, manufacturing and commercializing advanced human tissue-based products, announced the completion of its acquisition of the SimpliDerm hydrated human acellular dermal matrix…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

US appeals court sides with Sun Pharma in Lipitor antitrust case

US appeals court sides with Sun Pharma in Lipitor antitrust case

Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad

Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad